** Shares of Hims & Hers Health HIMS.N slip 3.1% premarket to $50.75 as telehealth firm seeks capital raise
** San Francisco, California-based firm offering privately $450 mln 5-yr convertible bonds
** Co says plans to use net proceeds for general purposes, including accelerating global expansion through organic growth and potential acquisitions
** Portion of net proceeds also to be used to pay for capped calls, derivative transactions employed to offset share dilution
** In other co news, it appointed Mo Elshenawy as chief technology officer. Elshenawy was most recently CTO at Cruise, self-driving vehicle firm owned by General Motors
** With ~223.8 mln shares outstanding, co has ~$11.7 bln market cap, per LSEG data
** On Apr 29, HIMS jumped 23% to close at $35.04 after Denmark's Novo Nordisk NOVOb.CO said it would sell its popular weight-loss drug Wegovy through telehealth firms to cash-paying U.S. customers
** Through Weds close, HIMS has risen nearly 90% over the past month and up 116.5% YTD
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.